Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease

Gary Tse, Jiandong Zhou, Sharen Lee, Wing Tak Wong, Xintao Li, Tong Liu, Zhidong Cao, Daniel Zeng, Abraham Ka Chung Wai, Ian Chi Kei Wong, Bernard Man Yung Cheung, Qingpeng ZhangJournal of Hypertension 2021 · DOI

Abstract

There was a significant relationship between ACEI/ARB use and COVID-19 positivity and severe disease after adjusting for significant confounders.
BibTeX
@article{tse2021relationship,
  author = {Gary Tse and Jiandong Zhou and Sharen Lee and Wing Tak Wong and Xintao Li and Tong Liu and Zhidong Cao and Daniel Zeng and Abraham Ka Chung Wai and Ian Chi Kei Wong and Bernard Man Yung Cheung and Qingpeng Zhang},
  title = {{Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease}},
  journal = {Journal of Hypertension},
  year = {2021},
  doi = {10.1097/hjh.0000000000002866},
}
Figure